BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20032162)

  • 1. Case 153: atypical tumefactive hypertrophic cardiomyopathy.
    Dillman JR; Mueller GC; Attili AK; Dorfman AL; Ensing GJ; Gordon D
    Radiology; 2010 Jan; 254(1):310-3. PubMed ID: 20032162
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy with restrictive phenotype and myocardial crypts.
    Cannavale A; Ordovás KG; Rame EJ; Higgins CB
    J Thorac Imaging; 2010 Nov; 25(4):W121-3. PubMed ID: 20463612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What is late gadolinium enhancement in hypertrophic cardiomyopathy?].
    Moon JC
    Rev Esp Cardiol; 2007 Jan; 60(1):1-4. PubMed ID: 17288947
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.
    Teraoka K
    Magn Reson Imaging; 2005 Jun; 23(5):701. PubMed ID: 16051047
    [No Abstract]   [Full Text] [Related]  

  • 6. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.
    Dimitrow PP
    Magn Reson Imaging; 2004 Nov; 22(9):1339. PubMed ID: 15607110
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypertrophic cardiomyopathy mimicking acute myocardial infarction: diagnostic role of cardiac magnetic resonance.
    Di Bella G; Bramanti O; Russo MS; Migliorato A; Anfuso C; Minutoli F; Arrigo F; Coglitore S
    Int J Cardiol; 2008 Apr; 125(3):e34-6. PubMed ID: 17368585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure.
    Yoshida A; Ishibashi-Ueda H; Yamada N; Kanzaki H; Hasegawa T; Takahama H; Amaki M; Asakura M; Kitakaze M
    Eur J Heart Fail; 2013 Feb; 15(2):166-75. PubMed ID: 23329703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Original report. Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging.
    Bogaert J; Goldstein M; Tannouri F; Golzarian J; Dymarkowski S
    AJR Am J Roentgenol; 2003 Apr; 180(4):981-5. PubMed ID: 12646440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging of hypertrophic cardiomyopathy.
    Cannavale A; Ordovás KG; Higgins CB
    J Thorac Imaging; 2013 Jan; 28(1):W12-8. PubMed ID: 20827222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contribution of magnetic resonance imaging to the diagnosis of 2 cases of cardiomyopathy].
    Zerbo F; Fiore D; Bressan M; Dalla Volta S
    Cardiologia; 1994 Oct; 39(10):737-40. PubMed ID: 7882396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed contrast enhancement CMR imaging in apical hypertrophic cardiomyopathy.
    Jassal DS; Chaithiraphan V; Neilan TG; Cury RC
    Int J Cardiol; 2006 Nov; 113(2):e56-7. PubMed ID: 16769137
    [No Abstract]   [Full Text] [Related]  

  • 13. Contrast-enhanced myocardial T1-weighted scout (Look-Locker) imaging for the detection of myocardial damages in hypertrophic cardiomyopathy.
    Amano Y; Takayama M; Kumita S
    J Magn Reson Imaging; 2009 Oct; 30(4):778-84. PubMed ID: 19787718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy (HCM): but what about 'apical' HCM?
    Dastidar AG; Rodrigues J; Bucciarelli-Ducci C
    Heart; 2014 Dec; 100(23):1898. PubMed ID: 25248754
    [No Abstract]   [Full Text] [Related]  

  • 15. Sub-aortic mitral impact lesion depicted by delayed enhancement cardiac magnetic resonance imaging.
    Sparrow P; Merchant N
    Eur Heart J; 2008 Oct; 29(19):2449. PubMed ID: 18390867
    [No Abstract]   [Full Text] [Related]  

  • 16. Sudden cardiac death prediction in hypertrophic cardiomyopathy using late gadolinium enhancement: trouble in paradise?
    Jellis CL; Desai MY
    Heart; 2014 Dec; 100(23):1821-2. PubMed ID: 25073886
    [No Abstract]   [Full Text] [Related]  

  • 17. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.
    Teraoka K; Hirano M; Ookubo H; Sasaki K; Katsuyama H; Amino M; Abe Y; Yamashina A
    Magn Reson Imaging; 2004 Feb; 22(2):155-61. PubMed ID: 15010107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophic cardiomyopathy: identification of morphological subtypes by echocardiography and cardiac magnetic resonance imaging.
    Syed IS; Ommen SR; Breen JF; Tajik AJ
    JACC Cardiovasc Imaging; 2008 May; 1(3):377-9. PubMed ID: 19356452
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy.
    De Cobelli F; Esposito A; Belloni E; Pieroni M; Perseghin G; Chimenti C; Frustaci A; Del Maschio A
    AJR Am J Roentgenol; 2009 Mar; 192(3):W97-102. PubMed ID: 19234246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are you calling me fat? An extreme case of cardiac lipomatosis masquerading as hypertrophic cardiomyopathy.
    Nunlist EH; Garcia J; Garg R
    Circ Cardiovasc Imaging; 2014 May; 7(3):563-5. PubMed ID: 24847010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.